Vorinostat Enhances the Activity of Temsirolimus in Renal Cell Carcinoma Through Suppression of Survivin LevelsDevalingam Mahalingam, Steffan T. Nawrocki, Ronan Swords et al.|Clinical Cancer Research|2009Cited by 121
Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinomaDevalingam Mahalingam, Steffan T. Nawrocki, Claudia M. Espitia et al.|British Journal of Cancer|2011Cited by 28
ELR510444 Inhibits Tumor Growth and Angiogenesis by Abrogating HIF Activity and Disrupting Microtubules in Renal Cell CarcinomaJennifer S. Carew, Steffan T. Nawrocki, Francis J. Giles et al.|PLoS ONE|2012Cited by 22